Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | 0 | reported | 23 May 2022 | tx 13+241,572−24,322 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 May 2022 | SALE | PhaseBio Pharmaceuticals Inc | 11,248 | 0.79 USD | |
| 20 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 11,248 | 0.68 USD | |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 18,750 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 87,500 | 0.00 USD | deriv |
| 19 Nov 2021 | SALE | PhaseBio Pharmaceuticals Inc | 5,766 | 2.37 USD | |
| 19 Nov 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 5,766 | 2.01 USD | |
| 20 May 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,811 | 2.80 USD | |
| 20 May 2021 | SALE | PhaseBio Pharmaceuticals Inc | 3,811 | 3.29 USD | |
| 05 Feb 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 36,000 | 0.00 USD | deriv |
| 23 Nov 2020 | SALE | PhaseBio Pharmaceuticals Inc | 3,497 | 3.45 USD | |
| 20 Nov 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,497 | 3.00 USD | |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 55,000 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 20,000 | 0.00 USD | deriv |